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Abstract Bone receives mechanical stimulation from
two primary sources, muscle contractions and external
gravitational loading; but the relative contribution of each
source to skeletal health is not fully understood. Under-
standing the most effective loading for maintaining bone
health has important clinical implications for prescribing
physical activity for the treatment or prevention of oste-
oporosis. Therefore, we investigated the relative effects of
muscle paralysis and reduced gravitational loading on
changes in muscle mass, bone mineral density, and mic-
roarchitecture. Adult female C57Bl/6J mice (n = 10/
group) underwent one of the following: unilateral botu-
linum toxin (BTX) injection of the hind limb, hind limb
unloading (HLU), both unilateral BTX injection and
HLU, or no intervention. BTX and HLU each led to
significant muscle and bone loss. The effect of BTX was
diminished when combined with HLU, though generally
the leg that received the combined intervention
(HLU?BTX) had the most detrimental changes in bone
and muscle. We found an indirect effect of BTX affecting
the uninjected (contralateral) leg that led to significant
decreases in bone mineral density and deficits in muscle
mass and bone architecture relative to the untreated
controls; the magnitude of this indirect BTX effect was
comparable to the direct effect of BTX treatment and
HLU. Thus, while it was difficult to definitively conclude
whether muscle force or external gravitational loading
contributes more to bone maintenance, it appears that
BTX-induced muscle paralysis is more detrimental to
muscle and bone than HLU.
Keywords Disuse  Botulinum toxin  Mechanical
loading  Tail suspension  Muscle–bone interaction 
Hind limb unloading  Paralysis
Introduction
Mechanical forces on bone, which are critical to skeletal
health, derive from two primary sources: external gravita-
tional loading via ground reaction forces and internal
loading via muscle contractions. The relative contribution
of muscle forces and external loading to skeletal health is
still debated [1–3], calling into question the theory
advanced by Frost [4] that muscle forces dominate bone
adaptation since they exert the largest forces on the skel-
eton. Understanding the most effective means of stimu-
lating bone formation or maintaining bone health via
mechanical loading has important clinical implications for
prescribing physical activity for the treatment or prevention
of osteoporosis.
Many different experimental unloading methods have
been used to manipulate the mechanical environment of
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bone in rodents, to improve our understanding of how bone
responds to mechanical forces. Rodent disuse models can
roughly be divided into two categories: (1) those that
remove or reduce external ground reaction forces but spare
muscle activation (e.g., hind limb unloading [HLU] [5],
limb immobilization [6], cast immobilization [7], partial
weight suspension [8]) and (2) those that eliminate muscle
contractions but permit external forces (e.g., botulinum
toxin [BTX] [9], neurectomy [10], tendon resection [11]).
Although these two categories are useful for generally
characterizing the disuse models, it is clear that the in vivo
situation is more complex than implied by these two broad
categories. Indeed, muscle and external forces are intri-
cately linked in vivo; and thus, it is impracticable to
manipulate one loading modality without affecting the
other. For instance, muscle contractions are permitted in
the HLU model, but muscle forces are theoretically
reduced since they need not oppose the torque of the
ground reaction forces. Analogously, in the BTX model,
intramuscular injection of BTX in hind limbs elicits tem-
porary muscle paralysis, which secondarily alters gait and
impacts external forces such that peak ground reaction
forces are reduced by 11 % 4 days after BTX injection
[12]. These limitations notwithstanding, these models are
valuable tools to study the relative musculoskeletal effects
of the removal of ground reaction forces versus the
removal of muscle forces.
In this regard, bone deterioration following muscle
paralysis via BTX injection is purportedly more rapid and
extreme than that seen with removal of ground reaction
forces via HLU [9, 13]. In contrast with this assertion,
Warden et al. [14] concluded that HLU has a greater
skeletal effect than BTX injection based on a study com-
bining HLU and BTX injection. However, Warden et al.
did not include normally loaded or HLU control groups
without BTX injection to be able to address the indepen-
dent effects of muscle paralysis relative to HLU.
To address the gap in knowledge regarding the relative
influence of external forces and muscle forces on skeletal
health, we removed one or both sources of mechanical
stimulus and studied the resulting bone and muscle
changes in adult mice. BTX-A injection into the primary
extensors of the left hind limb was used to eliminate
internal muscle forces, whereas HLU was used to elimi-
nate external ground reaction forces. An uninjected, nor-
mal, cage-dwelling group was also included as a control.
We included a group receiving both interventions com-
bined to evaluate if either mechanical stimulus acting
alone, i.e., in the groups receiving a single intervention,
limits bone loss relative to a condition of extreme disuse.
We hypothesized that BTX-induced muscle paralysis
would have a more detrimental effect on the skeleton than
HLU and that the combination of paralysis and unloading
would have a worse effect on muscle mass, bone mineral
density (BMD), and bone microarchitecture than either
intervention alone.
Materials and Methods
Experimental Design
Eleven-week-old, female C57Bl/6J mice (Jackson Labo-
ratory, Bar Harbor, ME) were assigned by body mass and
total-body BMD (TBBMD) to one of two housing condi-
tions (n = 20 each): (1) cage control group-housed in
standard vivarium cages or (2) HLU. These groups were
then further divided (n = 10 each) with half receiving
injections of BTX in one leg (CON?BTX, HLU?BTX)
and the other half receiving no injections (CON, HLU;
Fig. 1). HLU was initiated on day 0, and BTX injections
were performed 3 days prior so that the mice would have
maximal paralysis at the start of the unloading period. All
groups were provided with standard chow and water
ad libitum. The diets of BTX-injected groups were sup-
plemented with DietGel 76A and Hydrogel (ClearH2O,
Portland, ME) on the cage bottom to aid in access to food
and water. Body mass was monitored daily for the first
week and three times weekly thereafter. On day 21, mice
were euthanized via carbon dioxide inhalation. The pro-
tocol was approved by the Beth Israel Deaconess Medical
Center institutional animal care and use committee.
Fig. 1 Schematic of experimental design of four groups: CON
untreated and cage-dwelling, HLU untreated and hind limb–unloaded,
CON?BTX, injected with BTX in left leg and cage-dwelling;
HLU?BTX, injected with BTX in left leg and hind limb–unloaded
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Unilateral Hind Limb Muscle Paralysis by BTX
Injection
Three days prior to the start of the experiment, under
inhaled isoflurane anesthesia, the left leg of CON?BTX
and HLU?BTX mice was injected with BTX-A (2.5 U/
100 lL, BOTOX; Allergan, Irvine, CA) in the quadriceps
muscle group and the triceps surae, or calf, muscle group
(10 lL/muscle group). A total dose of 2 U/100 g was
chosen to be consistent with past studies [9, 14, 15]. The
contralateral leg served as an internal control and was not
injected with saline since past studies showed no negative
effects from saline injection [9, 16]. On day 1 of HLU (i.e.,
day 4 post–BTX injection), the HLU?BTX group had
significant weight loss and low activity, so each mouse was
given a subcutaneous injection of 0.6 mL lactated Ringer’s
solution for 2 days.
The degree of muscle paralysis was assessed in
HLU?BTX and CON?BTX groups on days -2, 0, 4, 7, 11,
14, and 18 using digit abduction scoring (DAS) and a
custom wire hang test. DAS was performed per the spec-
ifications of Aoki [17], in which mice are briefly suspended
by the tail to elicit a startle response comprising hind limb
extension and hind digit abduction. HLU animals, already
tail-suspended, were raised further by their tail until star-
tled. The DAS assay was scored on a scale of 0–4, where a
score of 0 indicated normal digit abduction and a score of 4
indicated maximal reduction in digit abduction with a
curved foot and all five digits touching. A custom wire
hang test was also used to evaluate upper hind limb
strength and complement the DAS in the event that the
HLU?BTX mice were unable to be startled after growing
accustomed to tail suspension. In this test, mice were
individually placed on top of a wire cage insert, the insert
was overturned, and the animal’s use of its injected hind
limb was scored on a scale of 0–3, where 0 indicated
normal ability to grip wire and hang body weight from the
injected hind limb and 3 indicated inability to flex the hip
and/or extend the leg to touch the foot to the wire cage
insert. An intermediate score of 2 indicated ability to bring
the leg toward the wire cage insert but not accurately place
the foot on wire, and with a score of 1 the mouse could
place the foot on the wire but not grip and support its
weight. Two observers independently performed the DAS
and wire hang test assessments at each time point, and their
scores were averaged.
Hind Limb Unloading
On day 0, mice in the HLU and HLU?BTX groups were
hind limb–unloaded via tail suspension following the rec-
ommendations of Morey-Holton and Globus [18–20].
Briefly, under isoflurane anesthesia, the tail was taped to a
freely rotating harness connected to a wheel that could
move along the central axis of the cage. The harness was
adjusted such that the mouse could not touch its hind paws
to the floor or the walls of the cage, leading to complete
removal of all ground reaction forces. However, muscle
contraction remained active in the non–BTX-injected
limbs.
BMD by Dual-Energy X-Ray Absorptiometry
BMD (grams per square centimeter) of the total body
(exclusive of the head) and both hind limbs (from femoral
neck to ankle) was assessed by peripheral dual-energy
X-ray absorptiometry (DXA, PIXImus II; GE Lunar,
Madison, WI), as described previously [20], at baseline
(day -3 or -4) and death.
Ex Vivo Muscle Measurements
Immediately after euthanasia, the gastrocnemius and soleus
muscles were dissected bilaterally and wet mass was
measured (±0.01 mg). Left and right muscle masses in
untreated mice were averaged together.
Bone Microarchitecture by Micro-computed
Tomography
Tibiae and femora were collected bilaterally from the
BTX-injected groups, while only right-sided bones from
the CON and HLU groups were analyzed, as BMD and
muscle data confirmed there were no bilateral differences
in the untreated groups. The bones were dissected, cleaned
of soft tissue, and fresh frozen at -20 C. Cortical and
trabecular bone microarchitecture of the tibia and femur
were assessed according to published guidelines [21] using
high-resolution micro-computed tomography (lCT40;
Scanco Medical, Bassersdorf, Switzerland) with a 12-lm
isotropic voxel size, as described previously [22]. Images
were acquired at 70 kVp and 114 mA, with 200 ms inte-
gration time. Three volumes were analyzed: proximal tibia
metaphysis (beginning 120 lm distal to the proximal
growth plate, extending 1,200 lm distally), midshaft tibia
(600 lm long beginning 2 mm proximal to the tibiofibular
junction), and distal femur metaphysis (beginning 240 lm
proximal to the distal growth plate, extending 1,800 lm
proximally). Gaussian filtration was applied to the gray-
scale images (r = 0.8, support = 1). Trabecular and cor-
tical bone were identified using automated algorithms and
segmented using a global threshold of 276 and
708 mg HA/cm3, respectively. Morphological analyses
were performed on the binarized images using direct, 3D
techniques that do not rely on any assumptions about the
underlying structure [23–25]. Morphometric variables of
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cancellous bone included bone volume fraction (Tb.BV/
TV, percent), trabecular thickness (Tb.Th, millimeters),
trabecular number (Tb.N, per millimeter), structure model
index (SMI), and degree of anisotropy (DA). Cortical bone
morphology measurements included average cortical
thickness (Ct.Th, millimeters), total cross-sectional area
(Tt.Ar, square millimeters), cortical bone area (Ct.Ar,
square millimeters), cortical area fraction (Ct.Ar/Tt.Ar,
percent), and polar moment of inertia (J, millimeters to the
fourth power).
Statistical Analysis
We used paired t-tests within each group to determine
whether body mass, BMD, and paralysis scores changed
from baseline to final. Differences in paralysis scores
between the HLU?BTX and CON?BTX groups were
analyzed using unpaired t-tests at each day. Differences in
body mass among groups on a given day were analyzed
using a two-way analysis of variance (ANOVA) for days 0,
1, 3, 7, and 21.
We defined a ‘‘direct effect’’ of BTX as the difference in
outcomes between the BTX-injected leg and the uninjected
(contralateral) leg within a mouse. To test for a direct effect
of BTX and the influence of unloading, we performed a two-
way ANOVA on data from both legs of the CON?BTX and
HLU?BTX groups, with unloading (HLU vs. cage control)
as a between-subject factor and BTX injection (BTX-injected
vs. uninjected) as a within-subject factor. We interpreted a
significant unloading 9 BTX injection interaction term to
indicate that the direct effect of BTX depended on loading
status. A paired t-test between the right and left limbs of
BTX-injected mice was used to test for the direct effect of
BTX within the HLU?BTX and CON?BTX groups.
We defined an ‘‘indirect effect’’ of BTX as the differ-
ence in outcomes between the uninjected leg of the BTX-
treated mice and their respective untreated control groups.
To test for an indirect effect of BTX and the influence of
unloading, we performed a two-way ANOVA using data
from only the uninjected legs of the CON?BTX and
HLU?BTX groups and the legs from the CON and HLU
groups, with unloading (HLU vs. cage control) and BTX
treatment (BTX-treated vs. untreated) as between-subject
factors. A significant unloading 9 BTX treatment interac-
tion term indicated that the indirect effect of BTX depen-
ded on loading status. An unpaired t-test between the CON
and HLU groups was used to test for the simple effect of
unloading.
To examine the contribution of weight loss to the indi-
rect effects of BTX, we performed a linear regression
between percent change in body mass and musculoskeletal
outcomes from the CON, HLU, and the uninjected leg of
the CON?BTX and HLU?BTX groups.
Differences were considered significant when p \ 0.05.
Results
One HLU?BTX mouse died before study completion and
was excluded from all analyses.
Body Mass
Body mass was similar in all groups at baseline.
CON?BTX and HLU?BTX mice lost weight steadily
after BTX injection, such that on unloading day 0 (3 days
after BTX injection) both groups weighed 11 % less than
the CON and HLU groups (Fig. 2). Following initiation of
suspension, HLU?BTX mice experienced further weight
loss, reaching a nadir of -22 % 2 days after suspension,
before rebounding to equal the weight of the CON?BTX
group at the completion of the study. A small deficit in
body mass remained in both BTX-treated groups by the
end of the study (p \ 0.001, day -3 vs. day 21). HLU mice
had transient weight loss up to -10 % on day 3, similar to
the effect of suspension on the HLU?BTX group, but by
day 21 returned to their baseline weight and were equal to
the weight of the CON group, whose body mass did not
change throughout the experiment.
Paralysis
Limb paralysis as assessed by DAS ensued within 1 day of
BTX injection and was maximal after 3 days (i.e., at the
start of HLU), with complete loss of digit abduction in
almost all mice (CON?BTX 3.80 ± 0.42, HLU?BTX
3.94 ± 0.17; Fig. 3a). Recovery was gradual over the
3 weeks of the study, with initial improvements in
CON?BTX outpacing the HLU?BTX group (day 4,
p \ 0.01). DAS observations in the HLU?BTX group
were unreliable after day 11 because it was not possible to
elicit a startle response in all mice.
Deficits in wire hang ability appeared more gradually
than DAS, but maximal paralysis also occurred on day 0
(3 days after BTX injection), with a complete inability to
reach the foot to the wire in almost all mice (CON?BTX
2.75 ± 0.42, HLU?BTX 2.83 ± 0.35; Fig. 3b). There was
a rapid recovery between days 0 and 7 that slowed there-
after, and only small deficits remained by day 18.
No paralysis was observed in the contralateral limb of
BTX-injected mice.
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Muscle Mass
HLU alone led to large decreases in soleus mass (-41.6 %,
HLU vs. CON, p \ 0.001; Fig. 4a), with no further
decrease when HLU was combined with BTX treatment
(p = 0.14). In contrast, BTX injection in normally loaded
mice led to a substantial decrease in soleus mass (-35 %,
p \ 0.001). Thus, the direct effect of BTX on soleus mass
was greater in normally loaded mice than those exposed to
HLU (pinteraction \ 0.001).
Gastrocnemius mass (Fig. 4b) was less affected than
soleus mass by HLU in untreated mice (-21.1 %,
p \ 0.001, HLU vs. CON). BTX did have a direct effect on
the gastrocnemius when combined with HLU (-41.1 %,
p \ 0.001 right vs. left leg). In normally loaded mice, the
BTX-induced decrease in gastrocnemius mass was even
greater (-52.1 %, p \ 0.001) than in HLU?BTX mice
(pinteraction \ 0.0001). Furthermore, there was no difference
in gastrocnemius mass in injected limbs of CON?BTX and
HLU?BTX mice, suggesting that BTX overwhelmed the
effect of unloading. There was an indirect effect of BTX
treatment on the gastrocnemius, such that gastrocnemius
mass of the uninjected leg was 25–30 % lower
(p \ 0.0001) than in the respective untreated controls
(Fig. 4b).
BMD
All groups were matched at baseline by total-body BMD,
averaging 0.0461 ± 0.0013 g/cm2. All further BMD data
are from measurements of the hind limbs since the exper-
imental disuse was intended to locally affect the hind limb.
In untreated mice, hind limb BMD increased in the CON
group (?4.6 % vs. baseline, p \ 0.001) and declined in the
HLU group (-4.9 % vs. baseline, p \ 0.01; Fig. 5) equally
in both legs. The BMD decline in the injected leg of
CON?BTX mice (-19.1 % vs. baseline, p \ 0.0001)
exceeded the decrease due to unloading alone (p \ 0.001).
BTX injection had a profound direct effect on BMD as
hind limb BMD declined approximately sixfold more in the
injected leg of the HLU?BTX group (-30.2 % vs. base-
line, p \ 0.0001) than the HLU group. However, BMD
also declined in the uninjected leg of the HLU?BTX group
(-17.8 % vs. baseline, p \ 0.0001), which exceeded the
effect from HLU alone, confirming an indirect effect of the
BTX injection. Further, the indirect negative effect of BTX
Fig. 2 Body mass changes
following injection of BTX on
day -3 and initiation of HLU on
day 0 (mean ± SE).
*Difference between day 21 and
initial measurement. On a given
day: a difference between CON
and CON?BTX, b difference
between HLU and HLU?BTX,
c difference between CON and
HLU, difference between
CON?BTX and HLU?BTX
Fig. 3 Scores on a digit
abduction and b wire hang
assessments of muscle paralysis
(mean ± SD). *Difference
between groups by day
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was greater in the HLU?BTX group than in the
CON?BTX group (pinteraction \ 0.01). In both BTX-treated
groups, there was a greater BMD decline in the injected
versus the contralateral leg (p \ 0.0001); however, the
direct effect of BTX was greater for the CON?BTX group
than the HLU?BTX group (pinteraction \ 0.001).
Bone Microarchitecture
At the end of the 21-day unloading period, untreated HLU
mice had significantly lower Tb.BV/TV (-28.2 %,
Fig. 6a), Tb.Th (-11.0 %), and DA and higher SMI in the
proximal tibia than the untreated CON group (p \ 0.01 for
all), with no differences in Tb.N (Table 1).
The direct effect of BTX injection on trabecular bone
microarchitecture was twice that of unloading alone as
Tb.BV/TV and Tb.Th of the CON?BTX injected leg were
a
b
Fig. 4 Effect of BTX and HLU on a soleus and b gastrocnemius
muscle mass (mean ± SD) Brackets indicate significant differences
(p \ 0.05) from respective control group. *p \ 0.05, BTX-injected
versus uninjected leg within loading group
Fig. 5 Effect of BTX and HLU on hind limb BMD (percent change
from baseline, mean ± SD). Brackets indicate significant differences
(p \ 0.05) from respective control group. *p \ 0.05, BTX-injected
versus uninjected leg within loading group
a
b
Fig. 6 Effect of BTX and HLU on trabecular bone volume fraction
of the a proximal tibia and b distal femur (mean ± SD). Brackets
indicate significant differences (p \ 0.05) from respective control
group. *p \ 0.05, BTX-injected versus uninjected leg within loading
group
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-46 and -24 % lower, respectively, than values for the
contralateral leg. In HLU?BTX mice, Tb.BV/TV
(-42.1 %) and Tb.Th (-26.3 %) were also lower in the
BTX-injected limb than the contralateral limb. The direct
effect of BTX was significantly less in HLU?BTX mice
than in normally loaded CON?BTX mice for Tb.BV/TV
and SMI (pinteraction \ 0.0001).
However, there was a substantial indirect effect of BTX
leading to deficits in Tb.BV/TV, Tb.N, Tb.Th, SMI, and
DA in the uninjected leg of both BTX-treated groups
compared to their respective HLU and CON untreated
control groups (p \ 0.02 for all; Fig. 6a, Table 1). This
indirect effect tended to be worse when combined with
unloading (pinteraction \ 0.05). For example, the deficit in
Tb.BV/TV due to the indirect effects of BTX was -36.5 %
for CON versus CON?BTX uninjected leg and -73.9 %
for HLU versus HLU?BTX uninjected leg. The indirect
effect of BTX in the HLU?BTX group exceeded the direct
effects of BTX; thus, the differences in trabecular bone
microarchitecture between the paired limbs of HLU?BTX
were much smaller than the differences between the
uninjected leg in the HLU?BTX group and the HLU
group. Overall, the worst trabecular architecture was seen
in the injected leg of the HLU?BTX group.
The differences in Tb.BV/TV at the distal femur were
consistent with those at the proximal tibia (Fig. 6), with
significantly lower trabecular bone resulting from unload-
ing and indirect BTX treatment but with less of a direct
BTX treatment effect than at the tibia.
At the tibial midshaft (Table 2), the HLU group had lower
Ct.Th, Ct.Ar, Ct.Ar/Tt.Ar, and J than the CON group
(p \ 0.05) but did not differ in Tt.Ar. Greater deficits
between the CON?BTX injected versus contralateral legs
were observed for Ct.Th, Ct.Ar, and Ct.Ar/Tt.Ar (p \ 0.01
for all) as a result of direct BTX treatment compared to
unloading alone. As noted for prior outcomes, the effect
of BTX was significantly less in the HLU?BTX
group than the CON?BTX group for Ct.Ar and Ct.Th
(pinteraction \ 0.02).
There was a significant indirect effect of BTX on cortical
bone morphology for every measure except Tt.Ar in both the
CON?BTX and HLU?BTX groups as the uninjected legs
Table 1 Trabecular bone microarchitecture of the proximal tibia (mean ± SD)
CON HLU
?BTX -BTX ?BTX -BTX
Tb.BV/TV [%]
Inj 5.03 ± 1.0abcd 1.86 ± 0.7d
Non 9.34 ± 1.2 14.72 ± 1.8efg 2.99 ± 0.7 10.57 ± 2.9
Tb.N [1/mm]
Inj 3.79 ± 0.21a 2.85 ± 0.31
Non 3.93 ± 0.30 4.24 ± 0.43efg 2.84 ± 0.40 3.86 ± 0.61
Tb.Th [mm]
Inj 0.037 ± 0.003abd 0.030 ± 0.002d
Non 0.049 ± 0.003 0.056 ± 0.003ef 0.040 ± 0.003 0.050 ± 0.005
SMI
Inj 3.31 ± 0.20acd 3.68 ± 0.17d
Non 3.04 ± 0.18 2.48 ± 0.24efg 3.95 ± 0.30 2.84 ± 0.30
DA
Inj 1.64 ± 0.10abd 1.27 ± 0.06d
Non 1.88 ± 0.11 2.00 ± 0.15ef 1.57 ± 0.11 1.82 ± 0.09
By ANOVA among both legs of BTX-treated groups, significant:
a Effect of unloading
b Effect of BTX injection
c Unloading 9 BTX injection interaction
d Paired t-test between uninjected and BTX-injected legs within group
By ANOVA among untreated controls and uninjected leg of BTX group, significant:
e Effect of unloading
f Effect of BTX treatment
g Unloading 9 BTX treatment interaction
?BTX BTX-treated groups, -BTX untreated controls, Inj injected leg, Non noninjected leg
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of the BTX groups differed from their respective CON and
HLU untreated controls (Table 2, p \ 0.01).
Indirect BTX Effect and Body Mass
Since the BTX-treated groups experienced a decline in
body mass while the CON and HLU groups did not, we
used linear regressions to examine whether weight loss
contributed to the indirect effects of BTX on bone and
muscle outcomes. The percent change in body mass
explained 38, 57, and 63 % of the variation in percent
change in BMD, final Tb.BV/TV, and final gastrocnemius
mass (p \ 0.0001 for all), respectively. Notably, when
unloading, BTX treatment, and percent change in body
mass were all included as independent variables in the
regression model, the model R2 improved to [0.9 and
unloading and BTX treatment were both significant pre-
dictors, whereas the effect of body mass did not remain
significant. Therefore, the indirect effect of BTX injection
is not completely explained by body mass changes.
Discussion
In this study, we generated an experimental model of
extreme disuse by combining hind limb muscle paralysis
and elimination of ground reaction forces to study mus-
culoskeletal atrophy. We hypothesized that combining hind
limb paralysis and unloading would have a greater dele-
terious effect on bone and muscle losses than either inter-
vention alone. In support of our hypothesis, the combined
HLU?BTX intervention had detrimental effects beyond
that of either intervention alone for most measurements
including hind limb BMD, trabecular bone volume fraction
and thickness at the proximal tibia and distal femur, and
midshaft tibial cortical bone area and thickness. Contrary
to our initial hypothesis, the combination of HLU?BTX
caused soleus atrophy equal to that of unloading alone and
gastrocnemius atrophy equal to that of BTX alone.
However, these conclusions are limited by our obser-
vation of a marked indirect (systemic) effect of BTX
treatment, manifested as lower BMD and worse bone
architecture in the uninjected legs in both BTX-treated
groups compared to their respective control groups with no
exposure to BTX. Moreover, the indirect effects on hind
limb BMD and tibial microarchitecture were nearly as
profound as those of direct BTX treatment of the injected
leg and often exceeded the effects of hind limb unloading
alone (Fig. 7). These results were unforeseen given that
other investigators encountered only minor and negligible
indirect effects using the same BTX dose as that used here
[9, 15]. Ultimately, it was difficult for us to evaluate the
Table 2 Cortical bone microarchitecture of the tibial midshaft (mean ± SD)
CON HLU
?BTX -BTX ?BTX -BTX
Ct.Th [mm] Inj 0.134 ± 0.012abcd 0.121 ± 0.012d
Non 0.163 ± 0.009 0.178 ± 0.005ef 0.136 ± 0.007 0.158 ± 0.011
Tt.Ar [mm2] Inj 0.845 ± 0.049b 0.859 ± 0.045d
Non 0.832 ± 0.060 0.891 ± 0.062 0.831 ± 0.046 0.837 ± 0.035
Ct.Ar [mm2] Inj 0.386 ± 0.025abcd 0.352 ± 0.029d
Non 0.455 ± 0.020 0.506 ± 0.025ef 0.391 ± 0.021 0.446 ± 0.035
Ct.Ar/Tt.Ar [%] Inj 45.8 ± 3.9abd 41.1 ± 3.7d
Non 54.9 ± 3.2 57.1 ± 5.8ef 47.1 ± 2.0 53.3 ± 4.9
J [mm4] Inj 0.081 ± 0.007bd 0.078 ± 0.008d
Non 0.090 ± 0.011 0.105 ± 0.013ef 0.081 ± 0.008 0.089 ± 0.011
By ANOVA among both legs of BTX-treated groups, significant:
a Effect of unloading
b Effect of BTX injection
c Unloading 9 BTX injection interaction
d Paired t-test between uninjected and BTX-injected legs within group
By ANOVA among untreated controls and uninjected leg of BTX group, significant:
e Effect of unloading
f Effect of BTX treatment
g Unloading 9 BTX treatment interaction
?BTX BTX-treated groups, -BTX untreated controls, Inj injected leg, Non noninjected leg
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relative potency of muscle paralysis and unloading on bone
and muscle since the indirect effects seen in the contra-
lateral limb likely contributed to the changes seen in the
BTX-injected limb.
The combined intervention used here was also recently
studied by Warden et al. [14], though they carried out HLU
for 6 weeks compared to our 3 weeks. Many of our results
are similar to theirs, such as some additional skeletal
effects of BTX-induced muscle paralysis when combined
with hind limb unloading and a diminished effect of BTX
treatment in HLU animals relative to BTX-injected cage
controls. Importantly, however, Warden et al. did not
include control groups without BTX injection, neither cage
controls nor HLU mice, and thus could not account for
possible indirect effects of BTX injection. Their conclu-
sions might be reconsidered in light of the results of the
current study demonstrating nonnegligible indirect effects
with BTX treatment. For instance, Warden et al. state that
HLU has a greater effect on bone than BTX treatment,
which they conclude by comparing the contralateral leg of
their HLU and BTX-treated group (subject to indirect
effects that were not quantified) to the treated leg of the
cage control group. We demonstrate that this reasoning
may be flawed since our HLU group that did not receive a
BTX injection fared better for every outcome than the cage
controls with BTX treatment. In fact, our results point to an
opposite conclusion to that of Warden et al., namely, that
BTX-induced muscle paralysis is more deleterious to bone
than HLU. As we hypothesized, the direct effect of BTX
exceeded the effect of unloading on hind limb BMD
(Fig. 7a), trabecular bone volume fraction (Fig. 7b) and
thickness, and cortical area fraction and thickness.
In general, we found greater negative indirect effects of
BTX treatment on muscle mass, bone mass, and bone
morphology than previously reported in studies of unilat-
eral BTX treatment in normally loaded animals [9, 15, 16,
26]. BTX-treated mice in the current study had a persistent
deficit in body mass compared to the control group, which
was also greater than that reported in past studies and may
have contributed to the observed indirect effects on bone
and muscle. The only major difference between the current
study and prior work is our use of younger animals
(11 weeks old rather than 15–16 weeks old). The BTX
treatment might have been more debilitating for these late
adolescent mice since they were still growing, albeit
slowly, at this age [27]. Mice receiving both a BTX
injection and HLU initially experienced early weight loss
and lethargy despite the prophylactic addition of diet sup-
plements and the 3-day interval between injection and
unloading to foster accommodation to the paralysis. Lac-
tated Ringer’s solution was given immediately on day 1
when their moribundity was apparent, and recovery
thereafter was swift. The CON?BTX group had less
weight loss, was more active, and appeared to be in better
health than the HLU?BTX group.
The ill health of the BTX-treated mice, though transient,
likely contributed to the indirect effects. The decrease in
body mass explained 38–63 % of the variation in muscu-
loskeletal outcomes in the uninjected leg of the BTX-
treated groups and their respective controls, accounting for
much of the observed indirect effects. It is possible that a
general reduction in activity in the BTX-injected groups
could also have contributed to bone and muscle atrophy,
particularly in the cage-control group, although we did not
Fig. 7 Relative effect of unloading, direct BTX treatment, and
indirect BTX treatment on a hind limb bone mineral density and
b proximal tibia trabecular bone volume fraction. The magnitude of
the effect of unloading (black bars) was calculated as the difference
between average values of the HLU and CON groups. The direct
effect of BTX alone (shaded bars) and BTX combined with unloading
(unshaded bars) was calculated as the difference between the injected
and contralateral limbs of the CON?BTX and HLU?BTX groups,
respectively. The indirect effect of BTX alone and combined with
unloading was calculated as the difference between the contralateral
leg of the CON?BTX or HLU?BTX group and the untreated CON or
HLU group, respectively
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quantify activity levels. Acute starvation with a concomi-
tant metabolic acidosis is known to cause a decline in bone
formation and stimulate calcium release directly from bone
[28] in addition to muscle degradation [29]; thus, the effect
of early body weight declines in the BTX-injected groups
on bone and muscle could be explained by this mechanism.
Finally, mice in the BTX groups were handled more
because they were weighed more frequently and paralysis
assessments were performed biweekly. This increased
handling may have led to greater stress levels in the BTX
groups and contributed to muscle atrophy and bone loss.
Distant effects arising from the local BTX injection itself
are also a possible, though less likely, contributor to the
observed indirect effects as there is evidence of retrograde
transport to the central nervous system [30], increase in
mean jitter of distant muscles [31, 32], and cholinergic
blockade [33]. There have not been any investigations into
the influence of BTX on bone signaling pathways that
would support a systemic effect. Since the indirect effect of
BTX was an unexpected finding, this experiment was not
designed to address its underlying mechanisms. Future
studies should measure metabolic, adrenocortical, and
physical activity to better understand the acute weight loss
following BTX injection in adolescent mice.
As use of the BTX injection model of disuse in rodents
increases, our results suggest it is important to bear in mind
the potential for indirect effects that may confound the
interpretation of how the elimination of muscle contrac-
tions influences bone adaptation. It is possible that the
potent skeletal effects of BTX treatment involved mecha-
nisms other than the direct action of muscle loading on
bone. Moreover, the contralateral leg may not serve as an
adequate control; and thus, groups of uninjected animals
may need to be included as additional controls.
Our study was limited in that we only studied a single
time point of 24 days post-injection to coincide with
maximal muscle atrophy and bone loss [16], so we cannot
discern whether the relative effects of HLU and BTX-
induced paralysis and indirect BTX effects would be the
same at earlier or later time points. Furthermore, we lacked
in vivo longitudinal measurements of bone microarchitec-
ture and muscle that would have allowed a more compre-
hensive examination of the rate and timing of bone and
muscle changes. Additionally, it is important to note that
BTX-induced paralysis leads to slightly reduced ground
reaction forces [9, 12] (-11 to -23 %), so it is not purely a
model of reduced muscle forces.
In conclusion, combining HLU and BTX injection
resulted in the greatest musculoskeletal impairment, though
the direct effect of BTX was diminished when combined
with unloading. Administered individually, BTX-induced
muscle paralysis appeared to have a greater detrimental
effect on bone than HLU, but strong indirect effects on the
uninjected legs of BTX-treated mice confounded our
interpretation of the relative contribution of forces from
muscle contraction versus external loading to skeletal
health.
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